Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lineage Cell Therapeutics, Inc. LCTX

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, a oligodendrocyte progenitor cell therapy for...

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

starting to look really good!

So we have a catalyst Q1/Q2 2021 on Dry AMD. A $10B market with no solution and LCTX might be the answer! I'm Long in BTI.V, LCTX, GERN, SLS, ICO.v, MMIRF, TNDM and recently went Long on...read more

TODAY 1PM - Meet CEO Brian Culley and CFO Brandi Roberts

**TODAY** - Nov 10th - virtual road show today with CEO Brian Culley and CFO Brandi Roberts. Register at no charge: https://attendee.gotowebinar.com/register/5866089557613760267  rate and reply

Nov 10th - Meet CEO Brian Culley and CFO Brandi Roberts

Mark your calendar - Nov 10th - virtual road show a week from today with CEO Brian Culley and CFO Brandi Roberts. Register at no charge: https://attendee.gotowebinar.com/register/5866089557613760267  rate and reply

LCTX - Early VAC2 Data Shows Promise

Lineage disclosed data from the Phase 1 clinical study of VAC2 for the treatment of non-small cell lung cancer (NSCLC), sponsored by partner Cancer Research UK (CR UK). The results showed ... https:/...read more

Noble Capital Markets initiates coverage

Research report released. See: https://www.channelchek.com/news-channel/Lineage_Cell_Therapeutics__LCTX____Initiating_Coverage__Eye_of_Stem_Cell_Treatments_and_Beyond  rate and reply